TCL Archive DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year May 12, 1978
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says April 20, 1990
TCL Archive Centers Subcommittee Suggests Construction Grant Guidelines; New Constructions Regulations Proposed March 28, 1975
